Chapel Hill Research Group Report issue

For profit Phase 3
Founded: Chapel Hill NC United States (2018)

Organization Overview

First Clinical Trial
2019
NCT04005755
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Chapel Hill Research Group

Active Ingredients

Drugs in Phase 3 Trials (2)

acetaminophen (tylenol) (1 trial)

ibuprofen (motrin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pain, Postoperative (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2